Stay updated with breaking news from Pedra Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Cedars-Sinai Accelerator and Technology Ventures teams, together with Coronet Ventures (Singapore) Pte. Ltd., a subsidiary of Cedars-Sinai Intellectual Prop
The Cedars-Sinai Accelerator and Technology Ventures teams, together with Coronet Ventures (Singapore) Pte. Ltd., a subsidiary of Cedars-Sinai Intellectual Prop
The Shockwave intravascular lithotripsy system produces a flash of light as it releases a sonic shockwave, as seen here as it is about to shatter a gypsum bead during a TCT 2019 demonstration at the vendor's booth. You can see the cracks forming as the bead breaks apart in the right bead. The technology combines a miniaturized lithotripsy system with a low-pressure balloon catheter to expand peripheral or coronary arteries without causing vessel trauma. Photo by Dave Fornell
Pedra Tissue Perfusion System Receives FDA Breakthrough Device Designation Novel perfusion monitor allows real-time, periprocedural monitoring of tissue perfusion in patients with critical limb threatening ischemia The Pedra Blood Perfusion Index tracks real-time changes in foot tissue perfusion attendant with balloon inflation and deflation during an angioplasty procedure. January 26, 2021 — Pedra Technology, a privately held company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company a Breakthrough Device Designation for the periprocedural use of its ...